Decision letter for "Impact of p16 Status on the Efficacy of Pembrolizumab Combined Nimotuzumab in Recurrent/Unresectable/Metastatic Head and Neck Squamous Cell Carcinoma Patients"

Publons reviews and discussion 2026

View at publisher

DOI: 10.1111/odi.70259/v2/decision1

Cited by: 0

Fields of Study & Subjects

Head and Neck Cancer Studies Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations